IGC Pharma GAAP EPS of -$0.02 beats by $0.01, revenue of $0.33M misses by $0.16M

* IGC Pharma press release [https://seekingalpha.com/pr/20205049-igc-pharma-reports-first-quarter-fiscal-2026-financial-results-company-accelerates-phase-2] (NYSE:IGC [https://seekingalpha.com/symbol/IGC]): Q1 GAAP EPS of -$0.02 beats by $0.01.
* Revenue of $0.33M (+22.2% Y/Y) misses by $0.16M.
* As of June 30, 2025, the company has not drawn on the $12 million available under the Credit Agreement with O-Bank.

MORE ON IGC PHARMA

* Seeking Alpha’s Quant Rating on IGC Pharma [https://seekingalpha.com/symbol/IGC/ratings/quant-ratings]
* Historical earnings data for IGC Pharma [https://seekingalpha.com/symbol/IGC/earnings]
* Financial information for IGC Pharma [https://seekingalpha.com/symbol/IGC/income-statement]